Crossmark

Celastrol-loaded PEG-<i>b</i>-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis

Crossref DOI link: https://doi.org/10.1039/C8BM01224E

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Allen, Sean D. https://orcid.org/0000-0001-7891-4230
Liu, Yu-Gang https://orcid.org/0000-0001-5304-3459
Kim, Taehyeung

Bobbala, Sharan https://orcid.org/0000-0002-0740-330X
Yi, Sijia

Zhang, Xiaohan

Choi, Jaehyuk https://orcid.org/0000-0003-2379-2226
Scott, Evan A. https://orcid.org/0000-0002-8945-2892
Funding

Funding for this research was provided by:

Division of Chemical, Bioengineering, Environmental, and Transport Systems (1453576)

NIH Office of the Director (1DP2HL132390-01)
License Information

Accepted Manuscript valid from 2019-12-18
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Sean D. Allen (ORCID)

: Yu-Gang Liu (ORCID)

: Yu-Gang Liu (ResearcherID)

: Sharan Bobbala (ORCID)

: Jaehyuk Choi (ORCID)

: Evan A. Scott (ORCID)

: Evan A. Scott (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 2 October 2018; Accepted 15 December 2018; Accepted Manuscript published 18 December 2018; Advance Article published 2 January 2019; Version of Record published 29 January 2019